Squarepoint’s Medline Inc MDLN Stock Holding History

Squarepoint’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,900,000	Closed	-$79.8M	–	5158
2025 Q4	$79.8M	Buy	+1,900,000	New	+$80.2M	0.08%	261

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Squarepoint's MDLN Position: Q1 2026 in Review

Squarepoint sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 1,900,000 shares — an estimated $79.8M sold.

Squarepoint first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $79.8M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Squarepoint reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
Squarepoint sold 1,900,000 Medline Inc shares in Q1 2026, an estimated $79.8M.
Squarepoint first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
Squarepoint's Medline Inc position peaked at $79.8M in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.